ZA987090B - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number: ZA987090B
Authority: ZA; South Africa
Prior art keywords: sup; formula; chemical compounds; mcp; disease
Prior art date: 1997-08-07

Application number

ZA987090A

Other languages

English (en)

Inventor

Alan Wellington Faull

Andrew John Barker

Jason Grant Kettle

Original Assignee

Zeneca Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-07

Filing date

1998-08-06

Publication date

1999-02-08

1998-08-06 Application filed by Zeneca Ltd filed Critical Zeneca Ltd

1999-02-08 Publication of ZA987090B publication Critical patent/ZA987090B/xx

Links

150000001875 compounds Chemical class 0.000 title abstract 2
101710155857 C-C motif chemokine 2 Proteins 0.000 abstract 2
102000000018 Chemokine CCL2 Human genes 0.000 abstract 2
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Transplantation (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Toxicology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Indole Compounds (AREA)
Mechanical Coupling Of Light Guides (AREA)
External Artificial Organs (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)

ZA987090A 1997-08-07 1998-08-06 Chemical compounds ZA987090B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9716657.3A GB9716657D0 (en)	1997-08-07	1997-08-07	Chemical compounds

Publications (1)

Publication Number	Publication Date
ZA987090B true ZA987090B (en)	1999-02-08

Family

ID=10817097

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA987090A ZA987090B (en)	1997-08-07	1998-08-06	Chemical compounds

Country Status (27)

Country	Link
US (2)	US6441004B1 (cs)
EP (1)	EP1003504B1 (cs)
JP (1)	JP3863722B2 (cs)
KR (1)	KR20010022318A (cs)
CN (1)	CN1265591A (cs)
AT (1)	ATE244007T1 (cs)
AU (1)	AU745907C (cs)
BR (1)	BR9811818A (cs)
CA (1)	CA2297290A1 (cs)
CZ (1)	CZ294600B6 (cs)
DE (1)	DE69816091T2 (cs)
DK (1)	DK1003504T3 (cs)
ES (1)	ES2201517T3 (cs)
GB (1)	GB9716657D0 (cs)
HR (1)	HRP20000061A2 (cs)
HU (1)	HUP0004301A3 (cs)
ID (1)	ID23666A (cs)
IL (1)	IL133989A0 (cs)
NO (1)	NO20000573L (cs)
NZ (1)	NZ502056A (cs)
PL (1)	PL338948A1 (cs)
PT (1)	PT1003504E (cs)
RU (1)	RU2217142C2 (cs)
SK (1)	SK284408B6 (cs)
TR (1)	TR200000289T2 (cs)
WO (1)	WO1999007351A2 (cs)
ZA (1)	ZA987090B (cs)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9716657D0 (en) *	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
FR2768146B1 (fr)	1997-09-05	2000-05-05	Oreal	Nouveaux composes de la famille des indole-carboxyliques et leur utilisation
GB9902459D0 (en) *	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902452D0 (en) *	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902461D0 (en) *	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902455D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902453D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
FR2796279B1 (fr)	1999-07-16	2001-09-21	Oreal	Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour le traitement de la seborrhee
FR2796274B1 (fr) *	1999-07-16	2001-09-21	Oreal	Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
GB0000626D0 (en) *	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds
GB0000625D0 (en) *	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds
PL366068A1 (en)	2000-10-10	2005-01-24	Smithkline Beecham Corporation	Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-gamma binding agents
WO2002060859A2 (en)	2000-12-20	2002-08-08	Bristol-Myers Squibb Company	Cyclic derivatives as modulators of chemokine receptor activity
CA2432908A1 (en)	2000-12-20	2002-06-27	Bristol-Myers Squibb Pharma Company	Diamines as modulators of chemokine receptor activity
CA2440803A1 (en)	2001-03-07	2002-09-12	Pfizer Products Inc.	Modulators of chemokine receptor activity
ES2180436B1 (es) *	2001-06-04	2003-11-01	Menarini Lab	Nuevos indoles como inhibidores de la ciclooxigenasa- ii
EP1314733A1 (en) *	2001-11-22	2003-05-28	Aventis Pharma Deutschland GmbH	Indole-2-carboxamides as factor Xa inhibitors
US7589199B2 (en)	2002-06-12	2009-09-15	Chemocentryx, Inc.	Substituted piperazines
DK1531822T3 (da)	2002-06-12	2009-12-07	Chemocentryx Inc	1-aryl-4-substituerede piperazin derivater til anvendelse som CCR1 antagonister til behandlingen af inflammation og immunforstyrrelser
US7842693B2 (en)	2002-06-12	2010-11-30	Chemocentryx, Inc.	Substituted piperazines
TW200508224A (en)	2003-02-12	2005-03-01	Bristol Myers Squibb Co	Cyclic derivatives as modulators of chemokine receptor activity
WO2004071449A2 (en)	2003-02-12	2004-08-26	Bristol-Myers Squibb Company	Lactams as modulators of chemokine receptor activity
WO2004080966A1 (ja)	2003-03-14	2004-09-23	Ono Pharmaceutical Co., Ltd.	含窒素複素環誘導体およびそれらを有効成分とする薬剤
WO2004092322A2 (en) *	2003-04-14	2004-10-28	Surface Logix, Inc.	Devices and assays for monitoring/measuring cellular dynamics to create subject profiles from primary cells
US7498323B2 (en)	2003-04-18	2009-03-03	Ono Pharmaceuticals Co., Ltd.	Spiro-piperidine compounds and medicinal use thereof
US7291615B2 (en)	2003-05-01	2007-11-06	Bristol-Myers Squibb Company	Cyclic derivatives as modulators of chemokine receptor activity
US7230133B2 (en)	2003-05-01	2007-06-12	Bristol-Myers Squibb Company	Malonamides and malonamide derivatives as modulators of chemokine receptor activity
US7732162B2 (en)	2003-05-05	2010-06-08	Probiodrug Ag	Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
WO2004108671A1 (en) *	2003-06-06	2004-12-16	Suven Life Sciences Limited	Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them
SE0302035D0 (sv) *	2003-07-09	2003-07-09	Biolipox Ab	New compound
US7332521B2 (en) *	2003-09-25	2008-02-19	Wyeth	Substituted indoles
US7381738B2 (en)	2004-02-19	2008-06-03	Bristol-Myers Squibb Company	Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
US7288563B2 (en)	2004-02-19	2007-10-30	Bristol-Myers Squibb Company	Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
US7230022B2 (en)	2004-02-19	2007-06-12	Bristol-Myers Squibb Company	Substituted fused bicyclic amines as modulators of chemokine receptor activity
US7479496B2 (en)	2004-02-19	2009-01-20	Bristol-Myers Squibb Company	Substituted spiro azabicyclics as modulators of chemokine receptor activity
US7435831B2 (en)	2004-03-03	2008-10-14	Chemocentryx, Inc.	Bicyclic and bridged nitrogen heterocycles
US7435830B2 (en)	2004-03-03	2008-10-14	Chemocentryx, Inc.	Bicyclic and bridged nitrogen heterocycles
WO2005101002A1 (en) *	2004-04-13	2005-10-27	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 2 (ccr2)
US8481035B2 (en)	2004-04-27	2013-07-09	Northwestern University	Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A
MXPA06014535A (es)	2004-06-18	2007-06-05	Biolipox Ab	Indoles utiles en el tratamiento de la inflamacion.
DE602005014233D1 (de) *	2004-06-18	2009-06-10	Biolipox Ab	Zur behandlung von entzündungen geeignete indole
RU2007101703A (ru) *	2004-06-18	2008-07-27	Биолипокс Аб (Se)	Индолы, полезные при лечении воспаления
MX2007000150A (es) *	2004-07-01	2007-03-30	Univ California	Inhibicion de moleculas pequenas de la interaccion del domini pdz.
EP1790637B1 (en)	2004-09-13	2014-01-29	Ono Pharmaceutical Co., Ltd.	Derivatives of N-4-piperidyl urea and medicaments containing them as active ingredient
GB0428173D0 (en) *	2004-12-23	2005-01-26	Astrazeneca Ab	Compounds
EP1676834A1 (en)	2004-12-30	2006-07-05	Sanofi-Aventis Deutschland GmbH	Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation
US20080249091A1 (en) *	2005-01-19	2008-10-09	Benjamin Pelcman	Indoles Useful in the Treatment of Inflammation
BRPI0519774A2 (pt)	2005-01-19	2009-02-10	Biolipox Ab	composto ou um sal farmaceuticamente aceitÁvel do mesmo, formulaÇço farmacÊutica, uso de um composto ou um sal farmaceuticamente aceitÁvel do mesmo, mÉtodo de tratamento de uma doenÇa em que inibiÇço da atividade de um membro da famÍlia mapeg É desejada e/ou necessÁria, produto combinado, e, processo para a preparaÇço de um composto
EP1841766A1 (en) *	2005-01-19	2007-10-10	Biolipox AB	Pyrrolopyridines useful in the treatment of inflammation
JP2008527028A (ja) *	2005-01-19	2008-07-24	バイオリポックスエービー	炎症の治療に有用なインドール類
US20090069384A1 (en) *	2005-01-19	2009-03-12	Biolipox Ab	Thienopyrroles useful in the treatment of inflammation
JP2008527030A (ja) *	2005-01-19	2008-07-24	バイオリポックスエービー	炎症の治療に有用なインドール類
US20110052612A1 (en)	2005-05-31	2011-03-03	Ono Pharmaceutical Co., Ltd.	Spiropiperidine compound and medicinal use thereof
PT1942108E (pt)	2005-10-28	2013-10-24	Ono Pharmaceutical Co	Composto com um grupo básico e a sua utilização
US8399666B2 (en)	2005-11-04	2013-03-19	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) *	2005-11-04	2010-03-17	Amira Pharmaceuticals Inc	5-Lipoxygenase-activating protein (FLAP) inhibitors
WO2007058322A1 (ja)	2005-11-18	2007-05-24	Ono Pharmaceutical Co., Ltd.	塩基性基を含有する化合物およびその用途
UA95788C2 (en) *	2005-12-15	2011-09-12	Ф. Хоффманн-Ля Рош Аг	Fused pyrrole derivatives
KR20090008217A (ko)	2006-03-10	2009-01-21	오노 야꾸힝 고교 가부시키가이샤	질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는 약제
US7732287B2 (en) *	2006-05-02	2010-06-08	Honeywell International Inc.	Method of forming a body-tie
EP2042503B1 (en)	2006-05-16	2013-01-30	Ono Pharmaceutical Co., Ltd.	Compound having acidic group which may be protected, and use thereof
WO2008000408A1 (en)	2006-06-28	2008-01-03	Sanofi-Aventis	Cxcr2 antagonists
KR20090023645A (ko)	2006-06-28	2009-03-05	사노피-아벤티스	신규한 ｃｘｃｒ2 억제제
JP5232144B2 (ja)	2006-06-28	2013-07-10	サノフイ	Ｃｘｃｒ２阻害剤
JP5352455B2 (ja)	2006-06-30	2013-11-27	サノフイ	Ｃｘｃｒ２阻害剤
WO2008016006A1 (fr)	2006-07-31	2008-02-07	Ono Pharmaceutical Co., Ltd.	Composé auquel un groupe cyclique est lié par une liaison spiro et son utilisation
ES2452343T3 (es) *	2006-09-29	2014-04-01	Glaxosmithkline Llc	Compuestos de indol sustituidos
KR20090074787A (ko) *	2006-10-05	2009-07-07	센토코 오르토 바이오테크 인코포레이티드	섬유증 치료용 ｃｃｒ2 길항제
EP2089383B1 (en)	2006-11-09	2015-09-16	Probiodrug AG	3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
US9126987B2 (en)	2006-11-30	2015-09-08	Probiodrug Ag	Inhibitors of glutaminyl cyclase
AU2008220785B2 (en)	2007-03-01	2013-02-21	Vivoryon Therapeutics N.V.	New use of glutaminyl cyclase inhibitors
MX2009011210A (es) *	2007-04-16	2009-10-30	Abbott Lab	Inhibidores de mcl1 de indol 7-no sustituido.
KR101511074B1 (ko)	2007-04-16	2015-04-13	애브비 인코포레이티드	7-치환된 인돌 Ｍｃｌ-1 억제제
JP5667440B2 (ja)	2007-04-18	2015-02-12	プロビオドルグエージー	グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
JP5580735B2 (ja) *	2007-06-12	2014-08-27	ジェネンテック，インコーポレイテッド	Ｎ−置換アザインドール類及び使用方法
WO2009089324A1 (en) *	2008-01-08	2009-07-16	Yale University	Compositions and methods for promoting patency of vascular grafts
US7964897B2 (en)	2008-07-22	2011-06-21	Honeywell International Inc.	Direct contact to area efficient body tie process flow
US8546431B2 (en)	2008-10-01	2013-10-01	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
JP5934645B2 (ja)	2009-09-11	2016-06-15	プロビオドルグエージー	グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
WO2011107530A2 (en)	2010-03-03	2011-09-09	Probiodrug Ag	Novel inhibitors
JP5688745B2 (ja)	2010-03-10	2015-03-25	プロビオドルグエージー	グルタミニルシクラーゼ（ｑｃ、ｅｃ２．３．２．５）の複素環阻害剤
WO2011131748A2 (en)	2010-04-21	2011-10-27	Probiodrug Ag	Novel inhibitors
EP2686313B1 (en)	2011-03-16	2016-02-03	Probiodrug AG	Benzimidazole derivatives as inhibitors of glutaminyl cyclase
EP2731439A4 (en) *	2011-07-12	2014-12-03	Merck Sharp & Dohme	TRKA KINASE INHIBITORS, COMPOSITIONS AND METHOD THEREFOR
US8883857B2 (en)	2012-12-07	2014-11-11	Baylor College Of Medicine	Small molecule xanthine oxidase inhibitors and methods of use
MA41051B1 (fr)	2014-10-06	2020-11-30	Vertex Pharma	Modulateurs du régulateur de conductance transmembranaire de la mucoviscidose
CA3007631A1 (en)	2015-12-11	2017-06-15	Research Institute At Nationwide Children's Hospital	Optimized patient specific non-linear tissue engineered vascular grafts
CA3019380A1 (en)	2016-03-31	2017-10-05	Vertex Pharmaceuticals Incorporated	Modulators of cystic fibrosis transmembrane conductance regulator
CN109803962B (zh)	2016-09-30	2022-04-29	弗特克斯药品有限公司	囊性纤维化跨膜传导调控蛋白的调节剂、以及药物组合物
US10610104B2 (en)	2016-12-07	2020-04-07	Progenity, Inc.	Gastrointestinal tract detection methods, devices and systems
MD3551622T2 (ro)	2016-12-09	2021-03-31	Vertex Pharma	Modulator al regulatorului conductanței transmembranare în fibroză chistică, compoziții farmaceutice, metode de tratament și procedeu pentru fabricarea modulatorului
CA3045310A1 (en)	2016-12-14	2018-06-21	Progenity, Inc.	Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
WO2018191146A1 (en) *	2017-04-10	2018-10-18	Navitor Pharmaceuticals, Inc.	Heteroaryl rheb inhibitors and uses thereof
US11253509B2 (en)	2017-06-08	2022-02-22	Vertex Pharmaceuticals Incorporated	Methods of treatment for cystic fibrosis
MA49631A (fr)	2017-07-17	2020-05-27	Vertex Pharma	Méthodes de traitement de la fibrose kystique
JP7121794B2 (ja)	2017-08-02	2022-08-18	バーテックスファーマシューティカルズインコーポレイテッド	ピロリジン化合物を調製するためのプロセス
ES2812698T3 (es)	2017-09-29	2021-03-18	Probiodrug Ag	Inhibidores de glutaminil ciclasa
WO2019079760A1 (en)	2017-10-19	2019-04-25	Vertex Pharmaceuticals Incorporated	CRYSTALLINE FORMS AND COMPOSITIONS OF CFTR MODULATORS
EP3720849A2 (en)	2017-12-08	2020-10-14	Vertex Pharmaceuticals Incorporated	Processes for making modulators of cystic fibrosis transmembrane conductance regulator
TWI810243B (zh)	2018-02-05	2023-08-01	美商維泰克斯製藥公司	用於治療囊腫纖化症之醫藥組合物
EP3774825A1 (en)	2018-04-13	2021-02-17	Vertex Pharmaceuticals Incorporated	Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
US20220249814A1 (en)	2018-11-19	2022-08-11	Progenity, Inc.	Methods and devices for treating a disease with biotherapeutics
CN121197633A (zh)	2019-12-13	2025-12-26	比特比德科有限责任公司	用于将治疗剂递送至胃肠道的可摄取装置

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3557142A (en)	1968-02-20	1971-01-19	Sterling Drug Inc	4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters
US3776923A (en)	1970-01-06	1973-12-04	American Cyanamid Co	2-nitro-4-oxo-4,5,6,7-tetrahydroindole
US3997557A (en)	1974-04-23	1976-12-14	American Hoechst Corporation	Substituted N-aminoalkylpyrroles
DE3115993A1 (de) *	1981-04-13	1982-11-11	Schering Ag, 1000 Berlin Und 4619 Bergkamen	Neue indol-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
US4384994A (en)	1981-10-08	1983-05-24	Merck & Co., Inc.	Renin inhibitory peptides
US4496742A (en)	1981-10-13	1985-01-29	The Upjohn Company	Analogs of 5,6-dihydro PGI2
FR2537974A1 (fr)	1982-12-16	1984-06-22	Adir	Nouveaux derives de thieno (2,3-b) pyrrole, leur procede de preparation et les compositions pharmaceutiques les renfermant
US4529724A (en)	1983-10-11	1985-07-16	Mcneilab, Inc.	6H-indolo[2,1-c][1,4]benzodiazepines and 12-oxo derivatives useful as antihypertensives
DE3342688A1 (de)	1983-11-25	1985-06-05	Siemens AG, 1000 Berlin und 8000 München	Roentgenroehre
FR2565981B1 (fr)	1984-06-15	1986-09-19	Adir	Nouveaux derives de thieno (2,3-b) pyrrole, leur procede de preparation et les compositions pharmaceutiques les renfermant
WO1986000896A1 (en)	1984-07-30	1986-02-13	Schering Corporation	NOVEL PROCESS FOR THE PREPARATION OF CIS, ENDOOCTAHYDROCYCLOPENTA ADb BDPYRROLE-2-CARBOXYLATE
PH23498A (en) *	1984-08-06	1989-08-16	Sterling Drug Inc	3-carbonyl-1-aminoalkyl-1h-indoles,composition and use thereof
JPS61100565A (ja) *	1984-10-22	1986-05-19	Green Cross Corp:The	インド−ル酢酸誘導体
US4675332A (en)	1984-12-10	1987-06-23	Warner-Lambert Company	Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
EP0189690B1 (en)	1984-12-12	1989-03-01	Merck & Co. Inc.	Substituted aromatic sulfonamides, their preparation and ophthalmic compositions containing them
US4721725A (en)	1986-01-27	1988-01-26	E. R. Squibb & Sons, Inc.	Aryl-cycloalkyl[b]pyrrole derivatives
NZ222878A (en)	1986-12-17	1991-02-26	Merck Frosst Canada Inc	3-hetero-substituted-n-benzyl-indole derivatives, and pharmaceutical compositions
US4751231A (en)	1987-09-16	1988-06-14	Merck & Co., Inc.	Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents
DE3907388A1 (de)	1989-03-08	1990-09-13	Kali Chemie Pharma Gmbh	Verfahren zur herstellung von indolcarbonsaeurederivaten
US5272145A (en)	1989-08-22	1993-12-21	Merck Frosst Canada, Inc.	(Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes
NZ234883A (en)	1989-08-22	1995-01-27	Merck Frosst Canada Inc	Quinolin-2-ylmethoxy indole derivatives, preparation and pharmaceutical compositions thereof
DE3943225A1 (de)	1989-12-23	1991-06-27	Schering Ag	Neue ss-carboline, verfahren zu deren herstellung und deren verwendung in arzneimitteln
US5081145A (en)	1990-02-01	1992-01-14	Merck Frosst Canada, Inc.	Indole-2-alkanoic acids compositions of and anti allergic use thereof
US5068234A (en) *	1990-02-26	1991-11-26	Sterling Drug Inc.	3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
US5260322A (en)	1990-10-08	1993-11-09	Merck & Co., Inc.	Angiotension II antagonists in the treatment of hyperuricemia
US5389650A (en)	1991-09-30	1995-02-14	Merck Frosst Canada, Inc.	(Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
CA2079374C (en)	1991-09-30	2003-08-05	Merck Frosst Canada Incorporated	(bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5190968A (en)	1991-09-30	1993-03-02	Merck Frosst Canada, Inc.	(Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5290798A (en)	1991-09-30	1994-03-01	Merck Frosst Canada, Inc.	(hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5308850A (en)	1991-09-30	1994-05-03	Merck Frosst Canada, Inc.	(Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5273980A (en)	1991-09-30	1993-12-28	Merck Frosst Canada Inc.	Bicyclic-azaarylmethoxy) indoles as inhibitors of leukotriene biosynthesis
RU2047603C1 (ru) *	1991-12-09	1995-11-10	Матвей Абрамович Рехтер	1-алкил-2-ацилиндолы и способы их получения
US5318985A (en)	1991-12-20	1994-06-07	Merrell Dow Pharmaceuticals Inc.	Potentiation of NMDA antagonists
WO1993016069A1 (en)	1992-02-13	1993-08-19	Merck Frosst Canada Inc.	(azaaromaticalkoxy)indoles as inhibitors of leukotriene biosynthesis
FI944602A0 (fi)	1992-04-03	1994-10-03	Upjohn Co	Farmaseuttisesti aktiiviset bisyklis-heterosykliset amiinit
US5334719A (en)	1992-06-17	1994-08-02	Merck Frosst Canada, Inc.	Bicyclic(azaaromatic)indoles as inhibitors of leukotriene bisynthesis
US5288743A (en)	1992-11-20	1994-02-22	Abbott Laboratories	Indole carboxylate derivatives which inhibit leukotriene biosynthesis
ZA939516B (en)	1992-12-22	1994-06-06	Smithkline Beecham Corp	Endothelin receptor antagonists
EP0639573A1 (de)	1993-08-03	1995-02-22	Hoechst Aktiengesellschaft	Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
US5852046A (en)	1993-08-03	1998-12-22	Hoechst Aktiengesellschaft	Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
US5401287A (en)	1993-08-19	1995-03-28	Ppg Industries, Inc.	Reduction of nickel sulfide stones in a glass melting operation
US5399699A (en)	1994-01-24	1995-03-21	Abbott Laboratories	Indole iminooxy derivatives which inhibit leukotriene biosynthesis
MX9700696A (es)	1994-07-27	1997-04-30	Sankyo Co	Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
US5482960A (en)	1994-11-14	1996-01-09	Warner-Lambert Company	Nonpeptide endothelin antagonists
WO1996018393A1 (en) *	1994-12-13	1996-06-20	Smithkline Beecham Corporation	Novel compounds
US5684032A (en)	1994-12-13	1997-11-04	Smithkline Beecham Corporation	Compounds
HUP9802034A3 (en)	1995-04-04	2000-04-28	Encysive Pharmaceuticals Inc H	Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin and use of the compounds
IT1282797B1 (it)	1995-04-21	1998-03-31	Colla Paolo	Pirril-(indolil)-aril-sulfoni e relativo processo di produzione ed impiego nella terapia delle infezioni da virus dell'aids
US5604253A (en)	1995-05-22	1997-02-18	Merck Frosst Canada, Inc.	N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
US5639780A (en)	1995-05-22	1997-06-17	Merck Frosst Canada, Inc.	N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
WO1997012613A1 (en) *	1995-10-05	1997-04-10	Warner-Lambert Company	Method for treating and preventing inflammation and atherosclerosis
ES2199348T4 (es)	1996-02-26	2010-10-19	ADVANCED RESEARCH & TECHNOLOGY INSTITUTE	Uso de inhibidores de carbonico anhidrasa para el tratamiento del edema macular.
JP3540495B2 (ja) *	1996-03-18	2004-07-07	三菱重工業株式会社	水素分離膜
WO1997035572A1 (en)	1996-03-28	1997-10-02	Smithkline Beecham Corporation	Carboxylic acid indole inhibitors of chemokines
EP0822185A1 (en)	1996-07-31	1998-02-04	Pfizer Inc.	B-3-adrenergic agonists as antidiabetic and antiobesity agents
JP2000516611A (ja)	1996-08-14	2000-12-12	ワーナー―ランバート・コンパニー	Ｍｃｐ―１アンタゴニストとしての２―フェニルベンズイミダゾール誘導体
GB9716657D0 (en)	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
GB9716656D0 (en)	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
HU227568B1 (en)	1997-12-24	2011-08-29	Sanofi Aventis Deutschland	Indole derivatives, as inhibitors os factor xa
GB9803228D0 (en)	1998-02-17	1998-04-08	Zeneca Ltd	Chemical compounds
GB9803226D0 (en)	1998-02-17	1998-04-08	Zeneca Ltd	Chemical compounds
GB9902461D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902452D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902453D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902455D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902459D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB0000626D0 (en)	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds
GB0000625D0 (en)	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds

1997
- 1997-08-07 GB GBGB9716657.3A patent/GB9716657D0/en active Pending
1998
- 1998-08-04 PL PL98338948A patent/PL338948A1/xx unknown
- 1998-08-04 CA CA002297290A patent/CA2297290A1/en not_active Abandoned
- 1998-08-04 IL IL13398998A patent/IL133989A0/xx unknown
- 1998-08-04 HU HU0004301A patent/HUP0004301A3/hu unknown
- 1998-08-04 TR TR2000/00289T patent/TR200000289T2/xx unknown
- 1998-08-04 DE DE69816091T patent/DE69816091T2/de not_active Expired - Fee Related
- 1998-08-04 NZ NZ502056A patent/NZ502056A/en unknown
- 1998-08-04 CZ CZ2000431A patent/CZ294600B6/cs not_active IP Right Cessation
- 1998-08-04 DK DK98937659T patent/DK1003504T3/da active
- 1998-08-04 PT PT98937659T patent/PT1003504E/pt unknown
- 1998-08-04 JP JP2000506944A patent/JP3863722B2/ja not_active Expired - Fee Related
- 1998-08-04 KR KR1020007000897A patent/KR20010022318A/ko not_active Ceased
- 1998-08-04 BR BR9811818-8A patent/BR9811818A/pt not_active IP Right Cessation
- 1998-08-04 HR HR20000061A patent/HRP20000061A2/hr not_active Application Discontinuation
- 1998-08-04 ES ES98937659T patent/ES2201517T3/es not_active Expired - Lifetime
- 1998-08-04 CN CN98807795A patent/CN1265591A/zh active Pending
- 1998-08-04 AT AT98937659T patent/ATE244007T1/de not_active IP Right Cessation
- 1998-08-04 RU RU2000105901/15A patent/RU2217142C2/ru not_active IP Right Cessation
- 1998-08-04 US US09/485,061 patent/US6441004B1/en not_active Expired - Fee Related
- 1998-08-04 AU AU86381/98A patent/AU745907C/en not_active Ceased
- 1998-08-04 ID IDW20000172A patent/ID23666A/id unknown
- 1998-08-04 WO PCT/GB1998/002341 patent/WO1999007351A2/en not_active Ceased
- 1998-08-04 EP EP98937659A patent/EP1003504B1/en not_active Expired - Lifetime
- 1998-08-04 SK SK167-2000A patent/SK284408B6/sk unknown
- 1998-08-06 ZA ZA987090A patent/ZA987090B/xx unknown
2000
- 2000-02-04 NO NO20000573A patent/NO20000573L/no not_active Application Discontinuation
2002
- 2002-07-15 US US10/194,969 patent/US6953809B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2201517T3 (es)	2004-03-16
IL133989A0 (en)	2001-04-30
HK1027979A1 (en)	2001-02-02
KR20010022318A (ko)	2001-03-15
US6953809B2 (en)	2005-10-11
JP2001513494A (ja)	2001-09-04
PL338948A1 (en)	2000-12-04
GB9716657D0 (en)	1997-10-15
WO1999007351A2 (en)	1999-02-18
EP1003504A2 (en)	2000-05-31
BR9811818A (pt)	2000-08-15
CZ294600B6 (cs)	2005-02-16
PT1003504E (pt)	2003-11-28
AU745907B2 (en)	2002-04-11
AU8638198A (en)	1999-03-01
HRP20000061A2 (en)	2000-12-31
ATE244007T1 (de)	2003-07-15
DE69816091T2 (de)	2004-05-19
CN1265591A (zh)	2000-09-06
SK1672000A3 (en)	2000-12-11
TR200000289T2 (tr)	2000-08-21
US20030119830A1 (en)	2003-06-26
DK1003504T3 (da)	2003-10-13
HUP0004301A3 (en)	2002-10-28
US6441004B1 (en)	2002-08-27
JP3863722B2 (ja)	2006-12-27
RU2217142C2 (ru)	2003-11-27
WO1999007351A3 (en)	1999-05-14
AU745907C (en)	2005-02-17
CA2297290A1 (en)	1999-02-18
NO20000573D0 (no)	2000-02-04
SK284408B6 (sk)	2005-03-04
HUP0004301A2 (hu)	2001-12-28
CZ2000431A3 (cs)	2000-05-17
DE69816091D1 (de)	2003-08-07
NZ502056A (en)	2002-02-01
EP1003504B1 (en)	2003-07-02
ID23666A (id)	2000-05-11
NO20000573L (no)	2000-02-04

Publication	Publication Date	Title
IL133989A0 (en)	2001-04-30	Chemical compounds
ZA987087B (en)	1999-02-08	Chemical compounds
ID27178A (id)	2001-03-08	Senyawa aminosikloheksil eter dan penggunaannya
CY1107391T1 (el)	2010-07-28	Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
DE60116761D1 (en)	2006-04-06	Adamantanderivate
SE0103836D0 (sv)	2001-11-16	Novel compounds
PL366198A1 (en)	2005-01-24	Novel compounds
SE9902987D0 (sv)	1999-08-24	Novel compounds
GB9813540D0 (en)	1998-08-19	Chemical compounds
HK1038744A1 (zh)	2002-03-28	用於治療炎性疾病的化合物
CA2260777A1 (en)	1998-02-12	Pentafluorobenzenesulfonamides and analogs
TW261616B (cs)	1995-11-01
AU2001290480A1 (en)	2002-04-08	Cyclized benzamide neurokinin antagonists for use in therapy
FI935800A0 (fi)	1993-12-22	Antidepressiva och mot Parkisons sjukdom verksamma foereningar
TR199801614T2 (xx)	1998-11-23	Peptit t�revleri